107 related articles for article (PubMed ID: 19033693)
1. Elevated serum leptin levels: a risk factor for non-small-cell lung cancer?
Terzidis A; Sergentanis TN; Antonopoulos G; Syrigos C; Efremidis A; Polyzos A; Dessypris N; Petridou ET
Oncology; 2009; 76(1):19-25. PubMed ID: 19033693
[TBL] [Abstract][Full Text] [Related]
2. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.
Jamieson NB; Brown DJ; Michael Wallace A; McMillan DC
Cytokine; 2004 Jul 21-Aug 7; 27(2-3):90-2. PubMed ID: 15242698
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of lifestyle and lung cancer associations by histological types.
Kubik A; Zatloukal P; Tomasek L; Dolezal J; Syllabova L; Kara J; Kopecky P; Plesko I
Neoplasma; 2008; 55(3):192-9. PubMed ID: 18348651
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with human small aggressive non small cell lung cancer.
Tammemagi CM; Freedman MT; Church TR; Oken MM; Hocking WG; Kvale PA; Hu P; Riley TL; Ragard LR; Prorok PC; Berg CD
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2082-9. PubMed ID: 17932357
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.
Karapanagiotou EM; Polyzos A; Dilana KD; Gratsias I; Boura P; Gkiozos I; Syrigos KN
Lung Cancer; 2009 Dec; 66(3):393-8. PubMed ID: 19282046
[TBL] [Abstract][Full Text] [Related]
7. Gender, age, usual weight, and tobacco use as predictors of weight loss in patients with lung cancer.
Brown JK
Oncol Nurs Forum; 1993 Apr; 20(3):466-72. PubMed ID: 8388561
[TBL] [Abstract][Full Text] [Related]
8. Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study.
Pasco JA; Jacka FN; Williams LJ; Henry MJ; Nicholson GC; Kotowicz MA; Berk M
J Affect Disord; 2008 Apr; 107(1-3):221-5. PubMed ID: 17727958
[TBL] [Abstract][Full Text] [Related]
9. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
[TBL] [Abstract][Full Text] [Related]
10. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).
Karapanagiotou EM; Tsochatzis EA; Dilana KD; Tourkantonis I; Gratsias I; Syrigos KN
Lung Cancer; 2008 Sep; 61(3):391-7. PubMed ID: 18342391
[TBL] [Abstract][Full Text] [Related]
11. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study.
Bolukbas FF; Kilic H; Bolukbas C; Gumus M; Horoz M; Turhal NS; Kavakli B
BMC Cancer; 2004 Jun; 4():29. PubMed ID: 15217519
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and lung cancer risk in Chinese.
Chen KY; Hsiao CF; Chang GC; Tsai YH; Su WC; Perng RP; Huang MS; Hsiung CA; Chen CJ; Yang PC;
Cancer; 2007 Oct; 110(8):1768-75. PubMed ID: 17879370
[TBL] [Abstract][Full Text] [Related]
14. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle: results from a European multicentre case-control study.
Ahrens W; Timmer A; Vyberg M; Fletcher T; Guénel P; Merler E; Merletti F; Morales M; Olsson H; Olsen J; Hardell L; Kaerlev L; Raverdy N; Lynge E
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):623-30. PubMed ID: 17625430
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden).
Myrdal G; Lamberg K; Lambe M; Ståhle E; Wagenius G; Holmberg L
Lung Cancer; 2009 Jan; 63(1):16-22. PubMed ID: 18571760
[TBL] [Abstract][Full Text] [Related]
17. [The incidence of sick euthyroid syndrome in non-small cell lung cancer patients].
Seyhan EC; Cetinkaya E; Altin S; Gençoğlu A; Simşek N
Tuberk Toraks; 2008; 56(2):163-70. PubMed ID: 18701976
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors of lung cancer in Tianjin].
Chen KX; Xu WL; Jia ZL; Yu M; Wang QS; Dong SF; Wang JF
Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):575-80. PubMed ID: 14690566
[TBL] [Abstract][Full Text] [Related]
19. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
[TBL] [Abstract][Full Text] [Related]
20. Is obesity a preventive factor for lung cancer?
Kollarova H; Machova L; Horakova D; Cizek L; Janoutova G; Janout V
Neoplasma; 2008; 55(1):71-3. PubMed ID: 18190245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
